Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FGEP6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,805
Award facts
- Contract value 100% obligated
- $19,804.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $19,804.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 200-unit vials of BOTOX. Issued on December 8, 2025, with an ultimate completion date of December 30, 2025, this delivery order carries no set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. This award is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) designated SPE2DR within the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036.
The PPV-G GEN V represents a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical supply delivery to Department of Defense healthcare facilities worldwide. As one of multiple regional prime vendor contractors under this program, DMS Pharmaceutical Group serves as a critical supplier of branded and generic pharmaceuticals, biologics, and medical consumables to support recurring military medical supply requirements. The vendor's selection reflects its established performance history and demonstrated capability to fulfill the specialized pharmaceutical needs of the federal military medical system across diverse therapeutic categories.
Quick answers
Who was awarded contract SPE2DR26FGEP6?
SPE2DR26FGEP6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FGEP6 worth?
The government has obligated $19,805 on SPE2DR26FGEP6.
Is contract SPE2DR26FGEP6 an order under another contract?
Yes. SPE2DR26FGEP6 is a delivery order under SPE2DR25D9312, an indefinite delivery contract.
Was contract SPE2DR26FGEP6 competed?
The extent of competition for SPE2DR26FGEP6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award